Finance

Beta
Lists
300705:SHE
Hunan Jiudian Pharmaceutical Co Ltd
CNÂ¥10.55
+0.29%
(+0.030) 1D
Jun 12, 3:04:13 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300705...
Open
CNÂ¥10.56
High
CNÂ¥10.71
Low
CNÂ¥10.44
Mkt. cap
5.28B
Avg. vol.
5.41M
Volume
6.37M
Dividend
3.79%
Quarterly dividend
CNÂ¥0.10
Ex-dividend date
May 28, 2026
P/E ratio
13.22
52-wk high
CNÂ¥20.66
52-wk low
CNÂ¥10.36
EPS
CNÂ¥0.80
Shares outstanding
500.29M
No. of employees
2K
Open
CNÂ¥10.56
High
CNÂ¥10.71
Low
CNÂ¥10.44
Mkt. cap
5.28B
Avg. vol.
5.41M
Volume
6.37M
Dividend
3.79%
Quarterly dividend
CNÂ¥0.10
Ex-dividend date
May 28, 2026
P/E ratio
13.22
52-wk high
CNÂ¥20.66
52-wk low
CNÂ¥10.36
EPS
CNÂ¥0.80
Shares outstanding
500.29M
No. of employees
2K
News stories
From sources across the web
About Hunan Jiudian Pharmaceutical Co Ltd
CEO-
Employees2.3K
FoundedJan 19, 2001
Headquarters-
SectorPharmaceutical industry
Websitehnjiudian.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
815.92M
756.09M
842.86M
595.24M
Cost of goods sold
203.72M
191.30M
270.16M
197.35M
Cost of revenue
203.72M
191.30M
270.16M
197.35M
Research and development expenses
61.73M
49.31M
44.26M
34.19M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
364.93M
382.02M
423.63M
294.96M
Operating expense
441.21M
414.63M
499.23M
327.97M
Total operating expenses
644.93M
605.93M
769.40M
525.32M
Operating income
170.99M
150.15M
73.47M
69.92M
Other non operating income
1.89M
-6.21M
-17.50M
-200.62K
EBT including unusual items
182.45M
127.10M
73.68M
61.03M
EBT excluding unusual items
170.52M
140.17M
51.82M
63.36M
Income tax expense
16.80M
12.16M
10.01M
6.77M
Effective tax rate
9.21%
9.57%
13.58%
11.09%
Other operating expenses
12.56M
-16.11M
30.68M
-1.15M
Net income
165.65M
114.94M
66.46M
56.74M
Net profit margin
20.30%
15.20%
7.88%
9.53%
Earnings per share
-
-
-
-
Interest and investment income
788.54K
296.23K
474.72K
270.58K
Interest expense
-3.27M
-3.95M
-4.56M
-6.64M
Net interest expenses
-2.48M
-3.65M
-4.09M
-6.37M
Depreciation and amortization charges
-
-
-
-
EBITDA
198.36M
173.22M
103.59M
100.05M
Gain or loss from assets sale
-
-
-50.73K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer